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EXECUTIVE SUMMARY 
Abstract: Coagulopathy in trauma patients occurs due to tissue injury, hemodilution (dilution of 
hematocrit and clotting factors), infusion of hypo-coagulable blood products (e.g., packed red 
blood cells), acidosis, hypothermia, continued blood loss, and depletion of clotting factors. The 
onset of coagulopathy begins with the initial tissue injury and evolves rapidly. Many factors need 
consideration when determining resuscitative treatment for the trauma victim. These factors 
include the amount of time for extraction from the field, transport time to a trauma center, 
associated weather, and treatment provided in route. This study compared two clinical laboratory 
pathways (Conventional Coagulation test and Rotational Thromboelastometry [ROTEM] whole 
blood assay) to determine the influence on morbidity and mortality when trauma patients 
received blood products perioperatively. 
Introduction: Coagulopathy can begin at the point of injury and is called acute coagulopathy of 
trauma or can be triggered in the presence of low body temperature, dilution, acidosis, and 
expenditure of clotting factors and is called trauma-induced coagulopathy. Coagulopathy is a 
critical condition and needs to be diagnosed early. Research on TEG/ROTEM whole blood 
assays indicates a promising future in the use of these tests and the diagnosis and therapeutic 
process for trauma patients.  
Methodology: A retrospective, case-control investigation was carried out at The Charleston 
Area Medical Center (CAMC) General Hospital Level 1 Trauma Center in West VA. The 
hypotheses tested was when ROTEM whole blood assays are used to diagnose and predict the 
number of blood products needed for patients receiving blunt force trauma or penetration to the 
abdomen, the morbidity and mortality rate will decrease.  
Results: The sample for the Conventional Coagulation Test consisted of 93 patients 18 years or 
older with an average age of 42. The sample for the TEG/ROTEM whole blood assay consisted 
of 43 patients 18 years or older with an average age of 44. There was no statistical significance 
between ROTEM and Conventional tests and ISS, age, BMI, LOS, or the number of blood 
products given a (p>0.05). No statistical significance was found between ROTEM and 
Conventional tests and gender, AIS, and priority level 1 or 2 with a (p>0.05). No statistical 
significance was found using the Fisher’s Exact test comparing ROTEM and Conventional tests 
and the development of CHF or Pulmonary Edema with a (p>0.05). The results indicated that the 
mortality rate was higher among the ROTEM group and was found to be statistically significant 
with (p<0.05) compared to the Conventional group. 
Discussion: CAMC General Hospital began using the ROTEM whole blood assay test on trauma 
patients in 2014. For this study, there were only 43 ROTEM cases that could be used compared 
to 100 Conventional Coagulation test cases. Future research should be conducted at CAMC 
General Hospital on trauma patients receiving blood transfusions and the use of ROTEM whole 
blood assay tests when more cases are available for comparison.  
Conclusion: The working hypothesis for this study was trauma patients who received blood 
transfusions guided by TEG/ROTEM whole blood assays received fewer blood products and had 
a decreased morbidity and mortality rate than those who received blood transfusions guided by 
Conventional Coagulation tests. Although, statistical significance was found between the 
mortality rate and the case group no significance was found supporting the hypothesis due to the 
lack of sufficient ROTEM cases.    
Key Words: aPTT, Blood Transfusion, Platelets, PT, ROTEM, TEG, Trauma 
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INTRODUCTION 
Background 
 Coagulopathy is a condition of decreased clotting factors. In 2016, Chang, Cardenas, 
Wade, and Holcomb reported that once a traumatic injury has occurred, the endothelium exhibits 
anticoagulant properties. These features include thrombomodulin, endothelial protein C 
receptors, and a glycocalyx element.  According to Hinsbergh (2011), different factors activate 
the cells within the endothelium to release these properties such as catecholamines, inflammatory 
mediators, thrombin, and hypoxia.  Cohen et al. (2012) reported that patients with a high Injury 
Severity Score (ISS) and shock become coagulopathic from the moment of damage. Brohi, 
Singh, Heron, and Coats (2003) stated an ISS greater than 45 upon admission indicates 
coagulopathy.  
According to Brohi et al. (2008), acute traumatic coagulopathy happens in the early phase 
of the injury and is due to shock. These authors go on to state shock activates the anticoagulant 
and fibrinolytic processes causing thrombomodulin to convert thrombin from a coagulant to an 
anticoagulant and activating protein C in the presence of hypoperfusion. Another study by Brohi, 
Cohen, and Davenport (2007), trauma-induced coagulopathy is characterized by dysfunction 
through hemodilution with fluid administration or massive blood transfusion, hypothermia, 
acidosis, or the consumption of clotting factors.  Also, trauma patients commonly have a source 
of uncontrolled hemorrhaging, and an immediate diagnosis of coagulopathy is necessary to 
provide appropriate interventions (Schochl, Maegele, Solomon, Gorlinger, and Wolfgang, 2012).  
Furthermore, once contributing factors have been considered such as extraction from the field, 
transport time to a trauma center, associated weather, and treatment provided in route, a baseline 
coagulation analysis must be obtained. Additionally, the conventional coagulation tests give an 
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analysis of the Prothrombin Time (PT), International Normalized Ratio (INR), and activated 
Partial Thromboplastin Time (aPTT) and are performed using only plasma (Schochl et al., 2012). 
TEG and ROTEM are whole blood viscoelastic tests providing analysis at the initiation 
of coagulation, the dynamics of clot formation, strength, and breakdown which provides a clear 
internal view of the patient’s medical condition (Schochl et al., 2012).   
Literature Review 
Conventional Coagulation test: 
 According to Chowdhury, Saayman, Findlay, and Collins (2004), conventional 
coagulation laboratory tests have been insufficient to determine the probability of bleeding or 
predicting low levels of clotting factors. Simmons, Pittet, and Pierce (2014) stated that 
conventional coagulation tests do not sufficiently evaluate the intricate processes that occur in a 
patient with Trauma-Induced Coagulopathy (TIC).  Furthermore, Conventional Coagulopathy 
tests are performed on platelet reduced plasma and cannot evaluate the clot strength which can 
produce negative results. Driessen et al., (2015), reported results from a web-based survey 
among those attending the 15th European Congress of Trauma and Emergency Surgery in 
Frankfurt, Germany in May of 2014. According to these authors, the results stated that out of 
29% who responded, more than 74% admitted to using the conventional coagulation tests for 
initial evaluation and continued monitoring of hemorrhaging trauma patients.  Chitlur et al. 
(2011), reported that routine laboratory tests including PT/INR, aPTT, and platelet function were 
used for analyzing bleeding disorders. Additionally, enhanced knowledge of the clotting cascade 
provided a better understanding of the function, at the cellular level, of white blood cells, red 
blood cells, and platelets. Da Luz, Nascimento, and Rizoli (2013) stated that standard 
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coagulation assays used plasma which did not include platelets or the cellular element and 
viscoelastic assays such as TEG or ROTEM uses whole blood samples. 
Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM): 
  According to Ostrowski, Sorensen, Larsen, and Johansson (2011), data indicated that 
TEG and ROTEM viscoelastic whole blood assays identified and distinguished which type of 
coagulopathy was present.  Furthermore, immediate recognition of coagulopathy is crucial to 
plan the appropriate transfusion regimen.  These authors also reported viscoelastic whole blood 
assays had been used to direct and monitor transfusion interventions in hemorrhaging trauma 
patients. Ostrowski et al. (2011), again stated TEG was specifically responsive to shifts in fibrin 
and platelet function, and it was beneficial to discover changes and defects in the body’s blood 
clotting ability perioperatively. Another study reported Thromboelastography provided 
immediate results of clot strength and reliable data on coagulation activity and executed target-
directed transfusion treatment for trauma patients (Bollinger, Seeberger, and Kenichi, 2012).  
According to Chitlur et al. (2011), TEG and ROTEM provide a total evaluation of the cellular 
components starting with the initial clot production and ending with clot lysis.  Hoffman and 
Monroe (2001) stated that hemostasis has three different levels of coagulation. These authors 
stated the first level is called initiation and takes place on the surface of the cells with tissue 
factor, the second level is amplification and occurs on the platelet surface causing platelet 
adhesion, and the final level is propagation where proteases and cofactors combine to generate 
thrombin.  According to Whiting and DiNardo, (2014), the primary clinical purpose for TEG or 
ROTEM whole blood assays is the prompt return of results which lead to giving fast proper 
attention to hemostatic deficiencies. Furthermore, TEG parameters include Clotting Index which 
assesses the initial formation of a clot, Clot Strength, Elasticity, Thrombo-dynamic Potential 
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Index obtained at maximum amplitude, Clot lysis at 30 and 60 minutes, and Estimated Percent 
Lysis.  Additionally, ROTEM parameters have included INTEM (contact activation), EXTEM 
(tissue factor activation), APTEM (contains aprotinin for inhibiting fibrinolysis), and FIBTEM 
(analysis of the fibrinogen contribution to clot strength) (Whiting and DiNardo, 2014).  
Significance 
 Coagulopathy is a serious condition and is diagnosed immediately. Identification of the 
type of coagulopathy and what interventions are necessary to sustain life are the first steps to 
recovery.  Conventional Coagulation tests utilize a small portion of the coagulation pathway 
whereas TEG and ROTEM whole blood assays use the initial clot formation and follow through 
to the breakdown of the clot.  
 Coagulopathy is evident upon admittance in 25% of patients involved in a traumatic 
event and contributes to an increase in mortality rate (Brohi et al., 2007).  Therefore, comparing 
the outcomes of conventional coagulation tests to viscoelastic whole blood assays can provide a 
better understanding of which pathway to utilize in diagnosing coagulopathy and appropriate 
interventions for trauma patients. 
Extensive research has been done on acute and trauma-induced coagulopathy. Research 
has indicated that the timing of laboratory evaluation is imperative. Coagulopathy presents in the 
acute phase immediately following a traumatic event due to the activation of protein C and 
fibrinolysis, or as trauma-induced coagulopathy due to hemodilution, consumption of clotting 
factors, acidosis, or hypothermia. The present study could enhance medical practice and improve 
trauma patient outcomes at Charleston Area Medical Center, in West Virginia and other 
hospitals. 
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METHODOLOGY 
Research Hypothesis 
The working hypothesis for this study was trauma patients who received blood 
transfusions guided by TEG/ROTEM whole blood assays received fewer blood products 
presented a decreased morbidity and mortality rate than those who received blood transfusions 
guided by Conventional Coagulation tests.    
Research Design and Setting 
This study was a retrospective, case-control investigation carried out at The Charleston 
Area Medical Center (CAMC) General Hospital Level 1 Trauma Center in West Virginia. A 
chart review of adult trauma patients who received blood products in response to Conventional 
laboratory assay results or lab results from TEG/ROTEM whole blood assays were compared.  
The case group consisted of trauma patients that had a TEG/ROTEM whole blood assay test, and 
the morbidity or mortality that resulted from the interventions provided.  The control group 
consisted of trauma patients that had a Conventional Coagulation test, and the morbidity or 
mortality rate that resulted from the interventions provided.  This study design allowed for the 
comparison of two laboratory pathways, statistical analysis, and the interventions provided.  
Sample Population with Description 
 The CAMC General Hospital is a level 1 Trauma Center qualified to provide total care 
for every form of injury (CAMC, 2017).  An examination of medical records was performed on 
136 priority one and two trauma patients who experienced blunt force trauma or penetration to 
the abdominal cavity between the dates of January 1, 2006, through August 1, 2016. The medical 
records were provided through CAMC EMR Sorian (Cerner, 2016). 
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The patient’s sample for this study were identified using the International Classification 
of Diseases, 9th and 10th revision, Clinical Modification (ICD-9-CM) or (ICD-10-CM) code for 
blunt force trauma or penetration of the abdominal cavity (Centers for Disease Control and 
Prevention, 2017). 
Inclusion Criteria:  
1)  Adult male or female patients were18 years of age or older. 
2) Patients who were involved in blunt force trauma or penetration to the abdominal cavity 
and admitted to the CAMC General Hospital Trauma Center Emergency Department. 
3) Priority 1 or 2 designated patients. Priority 1 (P1) or Priority 2 (P2) trauma patients were 
transferred to the highest-level trauma center within 30-minutes or if greater than 30-
minutes the patient should be transferred to a nearby facility that was able to resuscitate 
and stabilize the patient (West Virginia Department of Human Resources, 2017). 
Exclusion Criteria: 
1) Patients were younger than 18 years of age. 
2) Any patient undergoing elective surgery. 
3) Any patient considered non-trauma. 
Procedures and Protocol 
 A retrospective, case-control study was performed utilizing patient electronic medical 
records that experienced a traumatic event producing blunt force trauma or penetration to the 
abdominal cavity between January 1, 2006 and August 1, 2016.  Dependent variables included 
morbidities (CHF or Pulmonary edema) that developed resulting from the transfusions and the 
mortality rate. Patient demographic and clinical information was obtained and included: patients 
who experienced a traumatic event produced by blunt force trauma or penetration to the 
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abdominal cavity, age, ISS, body mass index (BMI), TEG or ROTEM whole blood assay test 
results, Conventional Coagulation test results (PT/INR, aPTT, and Platelets), LOS in the 
hospital, morbidities (CHF or Pulmonary Edema) developed resulting from intervention, and the 
mortality rate.  
 The ISS is a structural grading arrangement that supplies a comprehensive score for 
trauma patients with a combination of injuries (Osler, Nelson, and Bedrick, 1999). Additionally, 
each injury is given an Abbreviated Injury Scale (AIS) score which includes six body zones 
(Head, Face, Chest, Abdomen, Extremities). These authors also reported the greatest AIS 
number for the individual body zones are used and the three most predominantly injured regions 
scores are squared and totaled to provide an ISS score. Finally, the ISS ranges from 0-75, and if 
the AIS score is 6 (an un-survivable injury), the ISS score will inevitably be 75 (Osler et al., 
1999).  
Data Collection 
The information gathered for this retrospective case-control investigation came from 
existing data utilizing the patient’s electronic medical records (EMR) (Cerner, 2016).  Microsoft 
Excel was used to organize all data collection.  Each patient was given a number, letter, or both 
categorizing the data as it was collected and safeguarded the patient’s identification. This data 
came from emergency department records, anesthesia records, and from other units at CAMC 
where patients received care during the hospital stay. The demographic and clinical information 
obtained was included: patients who received blunt force trauma or penetration to the abdominal 
cavity, age, ISS, body mass index (BMI), TEG or ROTEM whole blood assay test results, 
Conventional Coagulation test results (PT/INR, aPTT, and Platelets), length of stay in the 
hospital, morbidities (CHF or Pulmonary Edema) developed resulting from intervention, and 
 8 
mortality rate. The BMI was calculated by a person’s weight and height and was used as a 
predictor of body fat composition (CDC, 2011). 
Statistical Analysis  
  The purpose of this study was to compare the outcomes using two laboratory pathways 
(TEG/ROTEM or Conventional Coagulation) in patients who were involved in a traumatic event 
that produced blunt force trauma or penetration to the abdominal cavity. Chi-square analysis was 
done comparing the mortality rate against ROTEM and Conventional Coagulation tests. A t-test 
was performed and compared means difference between two dependent variables (morbidity and 
mortality) with ISS, age, BMI, LOS, and the number of blood products given. Three logistic 
regression tests were performed to determine if there was an association between independent 
variables ROTEM, age, BMI, gender, ISS with the dependent variables morbidity (CHF and 
Pulmonary Edema) and mortality. A p-value <0.05 was considered statistically significant. The 
data was analyzed using SPSS Version 24 (SPSS IBM Company, 2017).  
RESULTS 
Presentation, Analysis, and Interpretation of the Data 
 The study sample consisted of 136 patients over the age of 18, presenting to CAMC 
General Hospital with a trauma injury of blunt force or penetration to the abdomen. The 
following mean for ISS is 26.29  12.1, BMI 28.68  11, the age of the group was 43.15  17.9, 
Number of Blood Products Used 20.36  35, and length of stay in the hospital 19.8  24.6 (Table 
1). Of the 136 patients, 101 (74.1%) were male, 35 (25.9%) were female, 4 (2.9%) developed 
CHF, 12 (8.8%) developed pulmonary edema and the mortality rate was 17 (12.5%), (Table 1). 
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Table 1: Demographic and Clinical Characteristics of Adult Trauma Patients who received Blunt 
Force Trauma or Penetration to the Abdomen 
 
 
 
Variables 
Total Sample Study Groups Statistical Value 
 
Total 
N=136 
Mean (SD)  
TEG/ROTEM Whole 
Blood Assay 
 N= 43 (31.6%) 
Mean (SD) 
Conventional 
Coagulation Test 
 N=93 (68.4%) 
Mean (SD) 
 
 
p-Value 
 
ISS 26.29 (12.1) 22.95 (11.5) 27.83 (12.1) NS 
Age (years) 43.15 (18) 44.56 (20) 42.49 (16.9) NS 
BMI (kg/m2) 28.68 (11) 30.12 (17.5) 28.01 (5.9) NS 
Hospital LOS (days) 19.81 (24.64) 18.51 (26.4) 20.41 (23.9) NS 
Number of Blood 
Products 
 
20.36 (34.94) 
 
28.28 (51.4) 
 
16.70 (23.3) 
 
NS 
Mortality (%) 
1 - Alive 
2 - Dead  
 
1 – 118 (86.8%) 
2 – 17 (12.5%) 
 
1 – 34 (79.1%) 
2 – 9 (20.9%) 
 
1 – 85 (91.4%) 
2 – 8 (8.6%) 
 
  
*0.043 
CHF (%) 4 (2.9%) 1 (2.3%) 3 (3.2%) NS 
Pulmonary Edema 
(%) 
12 (8.8%) 4 (9.3%) 8 (8.6%) NS 
Gender 
1 – Male 
2 - Female 
 
1 – 100 (74.1%) 
2 – 35 (25.9%) 
 
1 – 30 (69.8%) 
2 – 13 (30.2%) 
 
1 – 71 (76.3%) 
2 – 22 (23.7%) 
 
NS 
AIS ABD 
    2 – Moderate 
 3 – Serious 
4 – Severe 
 5 – Critical 
 
 
2 – 46 (33.8%) 
3 – 44 (32.4%) 
4 – 36 (26.5%) 
5 – 10 (7.4%) 
 
2 – 20 (46.5%) 
3 – 11 (25.6%) 
4 – 8 (18.6%) 
5 – 4 (9.3%) 
 
2 – 26 (28%) 
3 – 33 (35.5%) 
4 – 28 (30.1%) 
5 – 6 (6.5%) 
 
 
NS 
 
 
Priority 
1 and 2 
1 – 105 (77.2%) 
2 – 31 (22.8%) 
1 – 34 (79.1%) 
2 – 9 (20.9%) 
1 – 71 (76.3%) 
2 – 22 (23.7%) 
 
NS 
*Indicates Statistical Significance at p<0.05, NS = Not Significant (p> .05), SD = Standard Deviation, ISS = Injury Severity 
Score, BMI = Body Mass Index, LOS = Length of Stay, CHF = Congestive Heart Failure, TEG = Thromboelastography, 
ROTEM = Rotational Thromboelastometry, AIS= Abbreviated Injury Scale 
 Comparison of the ROTEM whole blood assay (case group) and Conventional 
Coagulation test (control group) did not show a mean difference between ISS, age, BMI, LOS, or 
the number of blood products which were not statistically significant (p>0.05).  Also, 
comparison of the case group (ROTEM whole blood assay) and control group (Conventional 
Coagulation test) did not show a statistical significance between gender, AIS, and Priority level 
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with a (p>0.05).  Mortality was associated with a higher percentage in case group (TEG/ROTEM 
whole blood assay) which was statistically significant (p<0.05), (Table 1).  
A Fisher’s Exact Test was performed comparing the use of ROTEM and Conventional 
Coagulation tests with the development of pulmonary edema. The results indicated that 3.8 out 
of 12 (33%) patients in the case group developed pulmonary edema with no statistical 
significance (p >0.05), and 8.2 out of 12 (66.7%) developed pulmonary edema in the control 
group with no statistical significance (p>0.05), (Table 2).  
Table 2: Fisher’s Exact Test Comparing ROTEM and Conventional Coagulation tests with 
Pulmonary Edema 
 
TEG/ROTEM Whole Blood Assa1 
(1/0) 
Total 0 1 
Pulmonary Edema 0 Count 85 39 124 
Expected Count 84.8 39.2 124.0 
% within Pulmonary Edema 68.5% 31.5% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
91.4% 90.7% 91.2% 
1 Count 8 4 12 
Expected Count 8.2 3.8 12.0 
% within Pulmonary Edema 66.7% 33.3% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
8.6% 9.3% 8.8% 
Total Count 93 43 136 
Expected Count 93.0 43.0 136.0 
% within Pulmonary Edema 68.4% 31.6% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
100.0% 100.0% 100.0% 
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 Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 
.018*a 1 .894   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .018* 1 .894   
Fisher's Exact Test    1.000 .562 
Linear-by-Linear Association .018 1 .894   
N of Valid Cases 136     
 
 A Fisher’s Exact Test was performed comparing the use of ROTEM and Conventional 
Coagulation tests and the development of CHF. The results indicated that of the patients in the 
case group, only 1 (25%) out of 4 patients developed CHF.  The results indicated that 3 out of 4 
(75%) patients in the control group developed CHF with no statistical significance (p>0.05), 
(Table 3). 
Table 3: Fisher’s Exact Test Comparing ROTEM and Conventional Coagulation tests with CHF  
 
TEG/ROTEM Whole Blood Assay 
(1/0) 
Total 0 1 
CHF (1/0) 0 Count 90 42 132 
Expected Count 90.3 41.7 132.0 
% within CHF (1/0) 68.2% 31.8% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
96.8% 97.7% 97.1% 
1 Count 3 1 4 
Expected Count 2.7 1.3 4.0 
% within CHF (1/0) 75.0% 25.0% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
3.2% 2.3% 2.9% 
Total Count 93 43 136 
Expected Count 93.0 43.0 136.0 
% within CHF (1/0) 68.4% 31.6% 100.0% 
% within TEG/ROTEM 
Whole Blood Assay (1/0) 
100.0% 100.0% 100.0% 
 12 
 Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .083a 1 .773   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .087 1 .768   
Fisher's Exact Test    1.000 .623 
Linear-by-Linear Association .083 1 .773   
N of Valid Cases 136     
 
 A Pearson Chi-Square test was performed comparing the ROTEM group and the 
mortality rate.  The results indicated that the mortality rate was higher among the ROTEM group 
9 (20.9%) compared to 8 (8.6%) in the Conventional group and was found to be statistically 
significant with (p<0.05), (Table 4). 
Table 4: Pearson Chi-Square Analysis of the ROTEM (case group) and the Mortality Rate 
 
TEG/ROTEM Whole Blood Assa1 (1/0) 
0 1 
Mortality 
(Alive-1 or Dead-2) 
1 Count 85 34 
Expected Count 81.4 37.6 
% within Mortality (Alive-1 or Dead-2) 71.4% 28.6% 
% within TEG/ROTEM Whole Blood 
Assa1 (1/0) 
91.4% 79.1% 
Std. Residual .4 -.6 
2 Count 8 9 
Expected Count 11.6 5.4 
% within Mortality (Alive-1 or Dead-2) 47.1% 52.9% 
% within TEG/ROTEM Whole Blood 
Assa1 (1/0) 
8.6% 20.9% 
Std. Residual -1.1 1.6 
Total Count 93 43 
Expected Count 93.0 43.0 
% within Mortality (Alive-1 or Dead-2) 68.4% 31.6% 
% within TEG/ROTEM Whole Blood 
Assa1 (1/0) 
100.0% 100.0% 
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 Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) Exact Sig. (1-sided) 
Pearson Chi-Square 4.086a 1 .043   
Continuity Correctionb 3.036 1 .081   
Likelihood Ratio 3.819 1 .051   
Fisher's Exact Test    .054 .044 
N of Valid Cases 136     
 
A t-test analysis was performed comparing the LOS between the ROTEM and 
Conventional groups with no statistical significance found (p>0.05), (Table 5). 
Table 5: T-test Analysis comparing LOS between ROTEM and Conventional Coagulation Tests 
 TEG/ROTEM Whole Blood 
Assay (1/0) N Mean Std. Deviation Std. Error Mean 
Length of Stay 0 93 20.41 23.912 2.480 
1 43 18.51 26.419 4.029 
 
 The ROTEM group was analyzed with a logistic regression test for the dependent 
variable Mortality with the independent variables of age, gender, BMI, ISS, and Number of 
blood products and no statistical significance was found (p>0.05), (Table 6). 
Table 6: Logistic Regression Analysis Comparing ROTEM with Mortality among Adult Trauma 
Patients Who Received Blood Products Following a Traumatic Blunt Force or Penetration to the 
Abdomen 
 B S.E. Wald df Sig. Exp(B) 
Step 1a Age .010 .015 .454 1 .501  1.010 
Gender M1 and F2 .578 .579 .997 1 .318 1.782 
BMI  .038 .030 1.645 1 .200 1.039 
Injury Severity Score (ISS) -.002 .026 .009 1 .926 .998 
TEG/ROTEM Whole Blood 
Assay 
.843 .569 2.193 1 .139 2.323 
Number of Blood Products 
Used 
.005 .007 .589 1 .443 1.005 
Constant -4.665 1.482 9.915 1 .002 .009 
Dependent Variable: Mortality. BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational Thromboelastometry 
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 The ROTEM group was analyzed with a logistic regression analysis between the 
dependent variable Morbidity (CHF), and the independent variables that included age, gender, 
BMI, ISS, and Number of blood products with no statistical significance found (p>0.05), (Table 
7). 
Table 7: Logistic Regression Analysis Comparing ROTEM with Congestive Heart Failure (CHF) 
among Adult Trauma Patients Who Received Blood Products Following a Traumatic Blunt 
Force or Penetration to the Abdomen  
 B S.E. Wald df Sig. Exp(B) 
Step 1a Age .213 .109 3.823 1 .051 1.237 
Gender M1 and F2 1.572 1.629 .931 1 .335 4.815 
BMI -.089 .125 .515 1 .473 .915 
Injury Severity Score (ISS) -.280 .200 1.960 1 .161 .755 
TEG/ROTEM Whole Blood 
Assay 
-2.869 2.130 1.815 1 .178 .057 
Number of Blood Products 
Used 
.034 .034 .993 1 .319 1.034 
Constant -11.378 6.259 3.305 1 .069 .000 
Dependent Variable: Morbidity (CHF). BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational 
Thromboelastometry 
 The ROTEM group was analyzed with a logistic regression analysis between the 
dependent variable Morbidity (Pulmonary Edema) and the independent variables of age, gender, 
BMI, ISS, and Number of blood products with no statistical significance found (p>0.05), (Table 
8). 
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Table 8: Logistic Regression Analysis Comparing ROTEM with Pulmonary Edema with Adult 
Trauma Patients Who Received Blood Products Following a Traumatic Blunt Force or 
Penetration to the Abdomen 
 B S.E. Wald df Sig. Exp(B) 
Step 1a Age .009 .018 .277 1 .599 1.009 
Gender M1 and F2 .439 .675 .422 1 .516 1.550 
BMI .016 .019 .654 1 .419 1.016 
Injury Severity Score (ISS) .040 .027 2.100 1 .147 1.041 
TEG/ROTEM Whole Blood 
Assay  
.045 .738 .004 1 .951 1.047 
Number of Blood Products 
Used 
.004 .007 .322 1 .571 1.004 
Constant -5.049 1.572 10.322 1 .001 .006 
Dependent Variable: Morbidity (Pulmonary Edema). BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational 
Thromboelastometry 
 
DISCUSSION 
Discussion of Study Results 
 It was indicated that TEG/ROTEM are not interrelated with routine coagulation tests (Da 
Luz et al., 2013). This study also identified that rapid TEG (r-TEG) provides the earliest 
prediction of blood products to be transfused and can be used as a point of care for the treatment 
of hemorrhaging trauma patients for faster results.  Schochl et al. (2012), reported that whole 
blood assay tests provided personalized therapy according to the needs of the trauma patient in 
contrast to the predetermined protocol of dispensing allogeneic blood products. These authors 
further stated how the individualized care decreased the risks of underestimating or 
overestimating the number of blood products needed. This present study revealed a statistical 
significance between the mortality rate and the case group indicating a higher percentage 
compared to the control group. It is difficult to determine if there is a clinical significance due to 
the limitations of this study and the lack of sufficient cases to support ROTEM use. For this 
study, there were only 43 ROTEM cases that could be used compared to 136 Conventional 
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Coagulation test cases. Therefore, there was not sufficient sample size to support the hypothesis 
for this study. Research has shown that TEG/ROTEM have been recommended as a point of care 
test for trauma patients and more facilities need to be trained how to use, calibrate, and 
understand the specialized variances in performing the test (Da Luz et al., 2013).  The use of 
ROTEM for trauma patients at CAMC General Hospital began in 2014 and, according to 
research studies, can provide future success in the diagnosis and therapeutic interventions for 
hemostasis.  
Study Limitations 
 Several limitations were identified in this study. There were not enough ROTEM cases 
for adequate comparison.  Another limitation included unknown preexisting co-morbidities or 
prescribed medications which could have influenced the treatment and outcome of trauma 
patients perioperatively. The final limitation was the ROTEM cases included in this study also 
had a Conventional Coagulation test done, and there was no indication as to which test the 
interventions were prescribed. 
IMPLICATIONS AND RECOMMENDATIONS 
A future study comparing ROTEM whole blood assays and Conventional Coagulation 
laboratory tests should be done when ROTEM has been utilized at CAMC General Hospital for a 
longer period, and enough ROTEM cases are available for collection. A prospective study could 
be done as ROTEM whole blood assay is being used for trauma cases to determine if there is 
clinical significance between the two laboratory pathways and the interventions provided. 
Another study on ROTEM use could be conducted to include a detailed prediction of the type 
and number of blood products to be given according to the ROTEM algorithm and the outcomes 
compared with Conventional Coagulation tests. Finally, a study can be conducted comparing the 
 17 
timing of the results provided for trauma patients with that of the timing of Conventional 
Coagulation tests results.  
CONCLUSION 
In this present study, the use of ROTEM whole blood assay resulting in fewer blood products 
infused and decreased morbidity and mortality rate could not be determined due to the limited 
number of ROTEM cases available.  Statistical significance was found between the mortality rate 
and the ROTEM group. The mortality rate among the ROTEM group was found to have a higher 
percentage and was statistically significant compared to the Conventional group.   
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